Genomic Health Q2 Revenues Swell 75 Percent on Strong Oncotype DX Sales | GenomeWeb
NEW YORK (GenomeWeb News) - Genomic Health yesterday said second-quarter revenues grew by 75 percent, R&D spending rose 93 percent, and net loss widened by 47 percent.
 
Total receipts for the three months ended June 30 increased to $14.7 million from $8.4 million year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.